2022
|
Invention
|
Stable formulations of 5,10-methylene-(6r)-tetrahydrofolic acid. The invention is directed toward... |
2021
|
Invention
|
Stable salt of 5,10-methylene-(6r)-tetrahydrofolic acid. The present invention is directed toward... |
2019
|
Invention
|
18f-saccharide-folates. 18F isotope is linked via a prosthetic group, more specifically via a pro... |
2018
|
Invention
|
New stable salt of 5,10-methylene-(6r)-tetrahydrofolic acid.
The present invention is directed t... |
2017
|
Invention
|
18f-labelled folates as pet radiotracers. 18F-folate radiopharmaceuticals, wherein fluorine-18 is... |
2016
|
Invention
|
Folate-conjugates and corresponding metal-chelate complexes for use in diagnostic imaging and rad... |
|
Invention
|
18f-labelled folates. 18F-folate radiopharmaceuticals, wherein the fluorine-18 is covalently link... |
2015
|
Invention
|
Stable pharmaceutical compositions of 5,10-methylenetetrahydrofolate.
This invention relates to ... |
|
Invention
|
18f-labelled folates. 18F-folate radiopharmaceuticals obtained by such method of synthesis and th... |
2014
|
Invention
|
Hemisulfate salt of 5,10-methylene-(6r)-tetrahydrofolic acid. The present invention is directed t... |
2013
|
Invention
|
18f-labelled folate/antifolate analogues. The present invention is directed towards new 18 F- fol... |
2012
|
Invention
|
18f-saccharide-folates. 18F isotope F is linked via a prosthetic group, more specifically via a p... |
|
Invention
|
18f-saccharide-folates. The present invention is directed towards new 18F-folate radiopharmaceuti... |
|
Invention
|
Folate conjugates of albumin-binding entities. The present invention is directed towards new trif... |
2010
|
Invention
|
Process for preparing crystalline polymorphic forms of (6r)-l-erythro-tetrahydrobiopterin dihydro... |
|
Invention
|
Use of folates for producing a preparation suitable for preventing and treating inflammation and ... |
|
Invention
|
Use of folates for the prevention and treatment of vascular diseases.
This invention relates to ... |
2009
|
Invention
|
Crystalline forms of (6r)-l-erythro-tetrahydrobiopterin dihydrochloride. Crystal forms of (6R)-L-... |
|
Invention
|
18f-labelled folates as pet radiotracers.
The present invention is directed towards new 18F-fola... |
|
Invention
|
18f-labelled folates as pet radiotracers. The present invention is directed towards new 18F-folat... |
2008
|
Invention
|
18f-labelled folates. 18F-folate radiopharmaceuticals, wherein fluorine-18 is covalently linked t... |
|
Invention
|
18f-labelled folates.
The present invention is directed towards a new method of synthesis of 18F... |
|
Invention
|
18f-labelled folates. The present invention is directed towards a method of synthesis of 18F-fola... |
|
Invention
|
18f-labelled folates. The present invention is directed towards new 18F-folate radiopharmaceutica... |
2007
|
Invention
|
Pharmaceutical composition comprising progestogens and/or estrogens and 5-methyl-(6s)-tetrahydrof... |
2006
|
Invention
|
Use of folates for the prevention and treatment of vascular diseases. This invention relates to t... |
|
Invention
|
Method for cell-specific targeting. Method for selective targeting of one or more effector moiety... |
|
Invention
|
Pharmaceutical composition comprising progestogens and/or estrogens and 5-methyl- (6s)-tetrahydro... |
2005
|
Invention
|
Ion measurement/calibration cell. A measurement/calibration cell for potentiometrically measuring... |
2004
|
Invention
|
Stable pharmaceutical compositions of 5,10-methylene tetrahydrofolate. This invention relates to ... |
2002
|
Invention
|
Process for the preparation of optically pure tetrahydropterins and derivatives, and specifically... |